Wound Care (Pharmacies) - Indonesia

Indonesia

Highlights

Revenue in the Wound Care market is projected to reach US$25.24m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.40%, resulting in a market volume of US$25.75m by 2029.
In global comparison, most revenue will be generated United States (US$1.04bn in 2024).
In relation to total population figures, per person revenues of US$0.09 are generated in 2024.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Wound Care (Pharmacies) market in Indonesia has been experiencing significant growth in recent years.

Customer preferences: Customers in Indonesia have shown a growing preference for wound care products available at pharmacies. This can be attributed to the convenience and accessibility of these products in pharmacies, which are widely distributed across the country. Additionally, customers trust the quality and effectiveness of wound care products available at pharmacies, as they are regulated and approved by the Indonesian authorities.

Trends in the market: One of the key trends in the wound care market in Indonesia is the increasing demand for advanced wound care products. As the healthcare infrastructure in the country continues to improve, there is a growing awareness and understanding of the benefits of advanced wound care products. These products offer faster healing, reduced risk of infection, and improved patient comfort, which are highly valued by both healthcare professionals and patients. Another trend in the market is the rising demand for wound care dressings. Dressings are widely used in the treatment of various types of wounds, including surgical wounds, burns, and chronic wounds. The increasing prevalence of chronic diseases such as diabetes and the aging population in Indonesia have contributed to the growing demand for wound care dressings. These products provide an effective barrier against bacteria and help in maintaining a moist wound environment, which promotes faster healing.

Local special circumstances: Indonesia is a country with a large population and a diverse healthcare landscape. The country is made up of thousands of islands, which poses challenges in terms of healthcare access and distribution of medical products. Pharmacies play a crucial role in bridging this gap by providing accessible and affordable wound care products to the population. Furthermore, the Indonesian government has been actively promoting the use of generic medications, including wound care products. This has resulted in increased availability and affordability of wound care products in pharmacies, making them more accessible to a larger population.

Underlying macroeconomic factors: The growth of the wound care market in Indonesia can also be attributed to favorable macroeconomic factors. The country has been experiencing steady economic growth, which has led to an increase in disposable income among the population. This has resulted in higher healthcare spending, including the purchase of wound care products. Additionally, the Indonesian government has been investing in the development of the healthcare sector, including the expansion of healthcare facilities and the improvement of healthcare services. This has created a conducive environment for the growth of the wound care market, as it has increased the demand for healthcare products and services. In conclusion, the Wound Care (Pharmacies) market in Indonesia is developing due to customer preferences for accessible and regulated products, the increasing demand for advanced wound care products and dressings, the role of pharmacies in bridging healthcare access gaps, the government's promotion of generic medications, and favorable macroeconomic factors such as economic growth and government investment in healthcare.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.